Literature DB >> 17673234

Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability.

Gioacchino Tedeschi1, Daria Dinacci, Luigi Lavorgna, Anna Prinster, Giovanni Savettieri, Aldo Quattrone, Paolo Livrea, Corrado Messina, Arturo Reggio, Giovanna Servillo, Vincenzo Bresciamorra, Giuseppe Orefice, Marcantonio Paciello, Arturo Brunetti, Andrea Paolillo, Gabriella Coniglio, Simona Bonavita, Alfonso Di Costanzo, Alessandra Bellacosa, Paola Valentino, Mario Quarantelli, Francesco Patti, Giuseppe Salemi, Enrico Cammarata, Isabella Simone, Marco Salvatore, Vincenzo Bonavita, Bruno Alfano.   

Abstract

BACKGROUND: Fatigue is a major problem in multiple sclerosis (MS), and its association with MRI features is debated.
OBJECTIVE: To study the correlation between fatigue and lesion load, white matter (WM), and grey matter (GM), in MS patients independent of disability.
METHODS: We studied 222 relapsing remitting MS patients with low disability (scores <or=2 at the Kurtzke Expanded Disability Status Scale). Lesion load, WM and GM were measured by fully automated, operator-independent, multi-parametric segmentation method. T1 and T2 lesion volume were also measured by a semi-automated method. Fatigue was assessed by the Fatigue Severity Scale (FSS), and patients divided in high-fatigue (FSS>or=5; n=197) and low-fatigue groups (FSS<or=4; n=25).
RESULTS: High-fatigue patients showed significantly higher abnormal white matter fraction (AWM-f), T1 and T2 lesion loads, and significant lower WM-f, and GM-f. Multivariate analysis showed that high FSS was significantly associated with lower WM-f, and GM-f. Females and highly educated patients were significantly less fatigued.
CONCLUSION: These results suggest that among MS patients with low disability those with high-fatigue show higher WM and GM atrophy and higher lesion load, and that female sex and higher levels of education may play a protective role towards fatigue. Furthermore, they suggest that in MS, independent of disability, WM and GM atrophy is a risk factor to have fatigue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17673234     DOI: 10.1016/j.jns.2007.07.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  31 in total

1.  Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.

Authors:  I Specogna; F Casagrande; A Lorusso; M Catalan; A Gorian; L Zugna; R Longo; M Zorzon; M Naccarato; G Pizzolato; M Ukmar; M A Cova
Journal:  Radiol Med       Date:  2012-06-22       Impact factor: 3.469

2.  Effect of eszopiclone on sleep disturbances and daytime fatigue in multiple sclerosis patients.

Authors:  Hrayr Attarian; Garrick Applebee; Angela Applebee; Bingxia Wang; Melissa Clark; Becky McCormick; Emma Salzman; Catherine Schuman
Journal:  Int J MS Care       Date:  2011

3.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

4.  Structural correlates for fatigue in early relapsing remitting multiple sclerosis.

Authors:  Janine Wilting; Hans O Rolfsnes; Hilga Zimmermann; Marion Behrens; Vinzenz Fleischer; Frauke Zipp; Adriane Gröger
Journal:  Eur Radiol       Date:  2015-05-31       Impact factor: 5.315

5.  BDNF Val66Met polymorphism and brain volumes in multiple sclerosis.

Authors:  D Dinacci; A Tessitore; A Russo; M L De Bonis; L Lavorgna; O Picconi; R Sacco; S Bonavita; A Gallo; G Servillo; L Marcuccio; M Comerci; P Galletti; B Alfano; G Tedeschi
Journal:  Neurol Sci       Date:  2010-10-16       Impact factor: 3.307

6.  Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.

Authors:  Robert J Fox; Christopher S Coffey; Merit E Cudkowicz; Trevis Gleason; Andrew Goodman; Eric C Klawiter; Kazuko Matsuda; Michelle McGovern; Robin Conwit; Robert Naismith; Akshata Ashokkumar; Robert Bermel; Dixie Ecklund; Maxine Koepp; Jeffrey Long; Sneha Natarajan; Srividya Ramachandran; Thomai Skaramagas; Brenda Thornell; Jon Yankey; Mark Agius; Khurram Bashir; Bruce Cohen; Patricia Coyle; Silvia Delgado; Dana Dewitt; Angela Flores; Barbara Giesser; Myla Goldman; Burk Jubelt; Neil Lava; Sharon Lynch; Augusto Miravalle; Harold Moses; Daniel Ontaneda; Jai Perumal; Michael Racke; Pavle Repovic; Claire Riley; Christopher Severson; Shlomo Shinnar; Valerie Suski; Bianca Weinstock-Gutman; Vijayshree Yadav; Aram Zabeti
Journal:  Contemp Clin Trials       Date:  2016-08-10       Impact factor: 2.226

Review 7.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 8.  Central fatigue in multiple sclerosis: a review of the literature.

Authors:  Pamela Newland; Angela Starkweather; Matthew Sorenson
Journal:  J Spinal Cord Med       Date:  2016-05-05       Impact factor: 1.985

9.  Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study.

Authors:  Renata Conforti; Mario Cirillo; Angela Sardaro; Giuseppina Caiazzo; Alberto Negro; Antonella Paccone; Rosaria Sacco; Maddalena Sparaco; Antonio Gallo; Luigi Lavorgna; Gioacchino Tedeschi; Sossio Cirillo
Journal:  Neuroradiology       Date:  2016-07-16       Impact factor: 2.804

10.  Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis.

Authors:  Maxim Bester; Mariana Lazar; Maria Petracca; James S Babb; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  J Neurol Sci       Date:  2013-05-01       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.